Holen Sie sich die Stockscreener-App
0.00
100.00%
-9.50
Poseida Therapeutics Inc Aktie (PSTX) Neueste Nachrichten
Roche to complete $1.5 billion acquisition of U.S. biopharma company Poseida - MSN
Poseida Therapeutics, Inc. (NASDAQ:PSTX) Shares Acquired by Barclays PLC - Defense World
Roche to close $1.5B acquisition of Poseida Therapeutics - MSN
Jane Street Group LLC Has $296,000 Holdings in Poseida Therapeutics, Inc. (NASDAQ:PSTX) - Defense World
Poseida Therapeutics Completes Merger with Roche Holdings, Inc. and Blue Giant Acquisition Corp. - Defense World
Poseida Therapeutics acquired by Roche Holdings - Investing.com Australia
Roche Finalizes Poseida Acquisition: This Cell Therapy Deal Feels Like A Win/Win (RHHBY) - Seeking Alpha
Major pharmaceutical company Roche buys cell and gene developer Poseida Therapeutics in $1.5 billion acquisition - BioProcess Insider
Poseida Therapeutics acquired by Roche Holdings By Investing.com - Investing.com South Africa
Roche completes tender offer for Poseida Therapeutics shares By Investing.com - Investing.com Canada
Roche Completes Biopharma Acquisition Worth Up To $1.5B - Law360
Poseida Therapeutics Undergoes Merger and Delisting Changes - TipRanks
Roche set to finalise $1.5bn Poseida Therapeutics takeover - Proactive Investors USA
Roche Finalizes Tender Offer for $1.5B Poseida Deal - TipRanks
Roche: Poseida acquisition nears completion -January 08, 2025 at 04:55 am EST - Marketscreener.com
Roche completes tender offer for Poseida Therapeutics shares - Investing.com India
Roche Completes Acquisition of Poseida TherapeuticsNews and Statistics - IndexBox, Inc.
Roche to close $1.5B acquisition of Poseida Therapeutics (OTCQX:RHHBY) - Seeking Alpha
Roche to complete acquisition of U.S. biopharma company Poseida - MSN
Roche to complete acquisition of U.S. biopharma company Poseida -January 08, 2025 at 01:35 am EST - Marketscreener.com
Roche purchases shares in tender offer for Poseida Therapeutics, Inc. - The Manila Times
Roche Completes Major Acquisition of Poseida Therapeutics with 66% Share Tender Success - StockTitan
Poseida Therapeutics (NASDAQ:PSTX) Reaches New 1-Year HighHere's What Happened - MarketBeat
Poseida announces US waiting period expiration for deal with Roche - MLex
Geode Capital Management LLC Sells 5,438 Shares of Poseida Therapeutics, Inc. (NASDAQ:PSTX) - Defense World
Poseida Therapeutics, Inc. (NASDAQ:PSTX) Shares Bought by Barclays PLC - MarketBeat
Poseida Therapeutics (NASDAQ:PSTX) Sees Strong Trading VolumeWhat's Next? - MarketBeat
Poseida Therapeutics stock soars to 52-week high of $9.59 By Investing.com - Investing.com Australia
Poseida Therapeutics (NASDAQ:PSTX) Sets New 1-Year HighHere's Why - MarketBeat
Poseida Therapeutics stock soars to 52-week high of $9.59 - Investing.com
PSTX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Poseida Therapeutics, Inc. Is Fair to Shareholders - Business Wire
Wellington Management Group LLP Reduces Position in Poseida Therapeutics, Inc. (NASDAQ:PSTX) - MarketBeat
Poseida Therapeutics (NASDAQ:PSTX) Sets New 52-Week HighHere's What Happened - MarketBeat
Charles Schwab Investment Management Inc. Increases Holdings in Poseida Therapeutics, Inc. (NASDAQ:PSTX) - Defense World
Poseida Therapeutics, Inc. (PSTX) Hits Fresh High: Is There Still Room to Run? - MSN
XTX Topco Ltd Increases Stake in Poseida Therapeutics, Inc. (NASDAQ:PSTX) - MarketBeat
Poseida Therapeutics executive chairman sells $283,866 in stock By Investing.com - Investing.com Canada
Poseida Therapeutics executive chairman sells $283,866 in stock - Investing.com
Poseida Therapeutics Named to Newsweek's List of the Top 200 America's Most Loved Workplaces for 2024 - The Eastern Progress Online
Poseida Therapeutics to Present at Two Upcoming Investor Conferences - The Eastern Progress Online
Poseida Therapeutics' SWOT analysis: gene therapy firm's stock shows promise amid challenges - Investing.com Nigeria
Poseida Therapeutics' SWOT analysis: gene therapy firm's stock shows promise amid challenges By Investing.com - Investing.com South Africa
0.35%
0.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):